OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The effect of DPP-4 inhibition to improve functional outcome after stroke is mediated by the SDF-1α/CXCR4 pathway
Fausto Chiazza, Harald Tammen, Hiranya Pintana, et al.
Cardiovascular Diabetology (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 53

Showing 26-50 of 53 citing articles:

Neuroprotective Effects of Diabetes Drugs for the Treatment of Neonatal Hypoxia-Ischemia Encephalopathy
Laura Poupon-Bejuit, Eridan Rocha‐Ferreira, Claire Thornton, et al.
Frontiers in Cellular Neuroscience (2020) Vol. 14
Open Access | Times Cited: 14

Stromal cell-derived factor-1α predominantly mediates the ameliorative effect of linagliptin against cisplatin-induced testicular injury in adult male rats
Rania A. Elrashidy, Rehab A. Hasan
Cytokine (2020) Vol. 136, pp. 155260-155260
Closed Access | Times Cited: 14

Cardiovascular protection by DPP-4 inhibitors in preclinical studies: an updated review of molecular mechanisms
Esraa M. Zakaria, Walaa M. Tawfeek, Mohamed H. Hassanin, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2022) Vol. 395, Iss. 11, pp. 1357-1372
Open Access | Times Cited: 8

The stromal cell-derived factor-1 α (SDF-1α)/cysteine-X-cysteine chemokine receptor 4 (CXCR4) axis: a possible prognostic indicator of acute ischemic stroke
Xianjun Huang, Mei Wan, Qian Yang, et al.
Journal of International Medical Research (2019) Vol. 47, Iss. 5, pp. 1897-1907
Open Access | Times Cited: 12

Effects of Thiazolidinedione and New Antidiabetic Agents on Stroke
Chang Ho Ahn, Soo Lim
Journal of Stroke (2019) Vol. 21, Iss. 2, pp. 139-150
Open Access | Times Cited: 12

Dipeptidyl peptidase-4 inhibitor-induced autoimmune diseases: Current evidence
Ayan Roy, Jayaprakash Sahoo, Niya Narayanan, et al.
World Journal of Diabetes (2021) Vol. 12, Iss. 9, pp. 1426-1441
Open Access | Times Cited: 11

Calpain: The regulatory point of cardiovascular and cerebrovascular diseases
Xiaolu Zhang, Yujia Zheng, Ziyu Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117272-117272
Open Access | Times Cited: 1

Linagliptin, the dipeptidyl peptidase‐4 enzyme inhibitor, lessens CHOP and GRP78 biomarkers levels in cisplatin‐induced neurobehavioral deficits: A possible restorative gateway
Omnia Safwat El‐Deeb, Gehan M. Soliman, Rasha Osama El‐Esawy
Journal of Biochemical and Molecular Toxicology (2020) Vol. 34, Iss. 9
Closed Access | Times Cited: 9

Linagliptin prevents left ventricular stiffening by reducing titin cleavage and hypophosphorylation
Ilona Cuijpers, Anna‐Pia Papageorgiou, Paolo Carai, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 25, Iss. 2, pp. 729-741
Open Access | Times Cited: 8

The many facets of CD26/dipeptidyl peptidase 4 and its inhibitors in disorders of the CNS – a critical overview
Hans‐Gert Bernstein, Gerburg Keilhoff, Henrik Dobrowolny, et al.
Reviews in the Neurosciences (2022) Vol. 34, Iss. 1, pp. 1-24
Closed Access | Times Cited: 5

Incretin-Based Antihyperglycemic Agents for the Management of Acute Ischemic Stroke in Patients with Diabetes Mellitus: A Review
Dimitrios Milonas, Triantafyllos Didangelos, Apostolos Hatzitolios, et al.
Diabetes Therapy (2019) Vol. 10, Iss. 2, pp. 429-435
Open Access | Times Cited: 7

The Stroke-Induced Increase of Somatostatin-Expressing Neurons is Inhibited by Diabetes: A Potential Mechanism at the Basis of Impaired Stroke Recovery
Fausto Chiazza, Hiranya Pintana, Grażyna Lietzau, et al.
Cellular and Molecular Neurobiology (2020) Vol. 41, Iss. 3, pp. 591-603
Open Access | Times Cited: 7

Dipeptidyl peptidase-4 inhibitors as new tools for cardioprotection
Marina Rankovic, Nevena Jeremić, Ivan Srejović, et al.
Heart Failure Reviews (2020) Vol. 26, Iss. 2, pp. 437-450
Closed Access | Times Cited: 7

GLP-1 secretion in acute ischemic stroke: association with functional outcome and comparison with healthy individuals
Martin Larsson, Cesare Patrone, Mia von Euler, et al.
Cardiovascular Diabetology (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 6

The treament of hyperglycemia in acute ischemic stroke with incretin-based drugs
Federica Ferrari, Antonio Moretti, R. F. Villa
Pharmacological Research (2020) Vol. 160, pp. 105018-105018
Closed Access | Times Cited: 6

The Potential for Multi-Disease Treatment: Applications of Dipeptidyl Peptidase Inhibitors
甜甜 李
Advances in Clinical Medicine (2024) Vol. 14, Iss. 07, pp. 1469-1477
Closed Access

Of mice and men: incretin actions in the central nervous system
Olivia M. Farr, Eleni Pilitsi, Christos S. Mantzoros
Metabolism (2019) Vol. 98, pp. 121-135
Closed Access | Times Cited: 3

An up-to-date evaluation of alogliptin benzoate for the treatment of type 2 diabetes
Jingbo Hu, Chun-Lin Yang, Hongbo Wang, et al.
Expert Opinion on Pharmacotherapy (2019) Vol. 20, Iss. 14, pp. 1679-1687
Closed Access | Times Cited: 3

Inflammatory-associated proteomic predictors of cognitive outcome in subjects with ELVO treated by mechanical thrombectomy
Benton Maglinger, Jordan P. Harp, Jacqueline A. Frank, et al.
BMC Neurology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 1

Editorial: Nutritional modulation of central nervous system development, maintenance, plasticity, and recovery
Ilaria Bertocchi, Silvia Turroni, Fausto Chiazza
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 1

The effects of DPP4 inhibitors on the levels of plasma catecholamines and their metabolites in patients with type 2 diabetes
Tae Hun Kim, Ki‐Young Lee, Ie Byung Park, et al.
Diabetes Research and Clinical Practice (2019) Vol. 156, pp. 107832-107832
Closed Access | Times Cited: 2

SDF-1α promotes repair of myocardial ischemic necrosis zones in rats.
Xinhua Cai, Zhanzhan Zhu, Yongchun Zhang, et al.
PubMed (2019) Vol. 12, Iss. 6, pp. 1956-1967
Closed Access

Scroll to top